Lucent BioSciences, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Lucent BioSciences, Inc. - overview
Established
2014
Location
West Vancouver, -, Canada
Primary Industry
Chemicals
About
Lucent BioSciences, Inc. is a Canadian company dedicated to sustainable agriculture, providing innovative crop input solutions that enhance environmental practices and optimize farming outcomes. Founded in 2014, Lucent BioSciences, Inc. is headquartered in West Vancouver, Canada, focusing on crop nutrition solutions.
The firm has completed 7 deals, with its most recent funding round, a Grant of USD 3. 6 mn, led by Pacific Economic Development Canada on November 7, 2023. The total amount raised by the company is USD 4. 2 mn.
The founders include Jason McNamee, Jose Toku, and Michael Riedijk, who also serves as the CEO. Lucent BioSciences, Inc. focuses on innovative crop input solutions that align with sustainable agricultural practices. The company’s core offerings include Soileos and Nutreos, which are smart fertilizers designed to upcycle plant-based co-products, thereby reducing waste and enhancing resource management.
These products aim to support farmers in optimizing crop yields while minimizing environmental impact. They cater to a diverse clientele, including agricultural producers and distributors, particularly in North America and select international markets. Lucent Bio actively collaborates with industry partners to develop custom formulations tailored to specific crop requirements and regional environmental conditions, ensuring that its products meet the unique needs of end users. Lucent Bio operates primarily through B2B transactions, establishing partnerships with local retailers and wholesalers who facilitate product distribution to end consumers.
Revenue is generated from the sale of its flagship products, Soileos and Nutreos, which are marketed to agricultural businesses seeking sustainable crop nutrition solutions. The company’s financial model includes structured pricing plans that reflect the unique formulations and environmental benefits of its products. Transactions often involve bulk purchases by retailers who then supply individual farmers, creating a streamlined channel that connects the firm’s innovative solutions directly to the end user. In November 2023, Lucent BioSciences, Inc.
secured a venture funding of USD 3. 6 mn led by PacifiCan. The company intends to use these funds to expedite the research and development of Nutreos and expand its global market presence.
Current Investors
AGT Food and Ingredients Inc., Protein Industries Canada, WUTIF Capital (VCC)
Primary Industry
Chemicals
Sub Industries
Agricultural Chemicals
Website
www.lucentbiosciences.com
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.